Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Antimicrob Agents Chemother 2013 May 4;57(5):2161-6. Epub 2013 Mar 4.

Mycobacteriology Research Section, Department of Infection and Immunity, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

The real magnitude of antituberculosis (anti-TB) drug resistance in Saudi Arabia is still unknown because the available data are based on retrospective laboratory studies that were limited to hospitals or cities. A representative national survey was therefore conducted to investigate the levels and patterns of anti-TB drug resistance and explore risk factors. Between August 2009 and July 2010, all culture-positive TB patients diagnosed in any of the tuberculosis reference laboratories of the country were enrolled. Isolates obtained from each patient were tested for susceptibility to first-line anti-TB drugs by the automated Bactec MGIT 960 method. Of the 2,235 patients enrolled, 75 cases (3.4%) were lost due to culture contamination and 256 (11.5%) yielded nontuberculous mycobacteria (NTM). Finally, 1,904 patients (85.2% of those enrolled) had available drug susceptibility testing results. Monoresistance to streptomycin (8.1%; 95% confidence interval [CI], 7.2 to 9.1), isoniazid (5.4%; 95% CI, 4.7 to 6.2), rifampin (1%; 95% CI, 0.7 to 1.3) and ethambutol (0.8%; 95% CI, 0.5 to 1.2) were observed. Multidrug-resistant TB (MDR-TB) was found in 1.8% (95% CI, 1.4 to 2.4) and 15.9% (95% CI, 15.4 to 16.5) of new and previously treated TB cases, respectively. A treatment history of active TB, being foreign-born, having pulmonary TB, and living in the Western part of the country were the strongest independent predictors of MDR-TB. Results from the first representative national anti-TB drug resistance survey in Saudi Arabia suggest that the proportion of MDR-TB is relatively low, though there is a higher primary drug resistance. A strengthened continuous surveillance system to monitor trends over time and second-line anti-TB drug resistance as well as implementation of innovative control measures, particularly among immigrants, is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.02403-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632946PMC
May 2013
17 Reads

Publication Analysis

Top Keywords

drug resistance
24
anti-tb drug
16
saudi arabia
12
resistance saudi
8
representative national
8
national survey
8
drug
7
95%
6
resistance
6
anti-tb
5
mdr-tb 18%
4
95% confidence
4
confidence interval
4
81% 95%
4
testing monoresistance
4
monoresistance streptomycin
4
streptomycin 81%
4
interval [ci]
4
susceptibility testing
4
isoniazid 54%
4

Similar Publications